Sonendo

87 articles about Sonendo

• Sonendo to Participate at the Goldman Sachs 44th Annual Global Healthcare Conference

  5/31/2023

  Sonendo, Inc. today announced that management will participate in the upcoming Goldman Sachs 44th Annual Global Healthcare Conference.

• Sonendo, Inc. Announces Inducement Grants Under NYSE Listing Rule 303A.08

  5/23/2023

  Sonendo, Inc. announced that on May 23, 2023, the Compensation Committee of Sonendo’s Board of Directors granted restricted stock unit awards covering an aggregate of 300,000 shares of its common stock to two new, non-executive employees to induce them to join the Company.

• Sonendo Surpasses 1,000 GentleWave® Systems in the Market

  5/10/2023

  Sonendo, Inc., a leading dental technology company and developer of the GentleWave® System, announced that more than 1,000 GentleWave Systems are now in the market, furthering the company’s commitment to saving teeth and improving lives.

• Sonendo, Inc. Reports First Quarter 2023 Financial Results

  5/9/2023

  Sonendo, Inc., a leading dental technology company and developer of the GentleWave® System, reported financial results for the quarter ended March 31, 2023.

• Sonendo Sponsors Save Your Tooth Month 2023 in Partnership with the American Association of Endodontists (AAE); Will Also Participate in the 2023 AAE Annual Meeting

  4/26/2023

  Sonendo, Inc., a leading dental technology company and developer of the GentleWave® System, announced its sponsorship of Save Your Tooth Month 2023, a public awareness campaign aimed at promoting the benefits of saving natural teeth through endodontic treatment.

• Sonendo, Inc. to Report First Quarter 2023 Financial Results on May 9, 2023

  4/18/2023

  Sonendo, Inc. today announced that it will report financial results for the first quarter 2023 after the market close on Tuesday, May 9th , 2023.

• Sonendo Announces New Leadership in Operations and R&D

  4/6/2023

  Sonendo, Inc. (NYSE: SONX), a leading dental technology company and developer of the GentleWave® System, today announced changes to its leadership team.

• Sonendo Inc. Reports Fourth Quarter and Full Year 2022 Financial Results and Issues Full Year 2023 Revenue Guidance

  3/8/2023

  Sonendo, Inc., a leading dental technology company and developer of the GentleWave® System, reported financial results for the quarter and year ended December 31, 2022.

• Sonendo Continues to Invest in University Endodontic Programs, Research and Development Initiatives and Professional Education

  2/28/2023

  Sonendo, Inc., a leading dental technology company and developer of the GentleWave® System, announced its continued investment in endodontics, with a specific focus on clinical training and education.

• Sonendo, Inc. to Report Fourth Quarter and Full Year 2022 Financial Results on March 8, 2023

  2/15/2023

  Sonendo, Inc., a leading dental technology company and developer of the GentleWave® System, announced that it will report financial results for the fourth quarter and full year 2022 after the market close on Wednesday, March 8th, 2023.

• Sonendo Reveals New Survey Data, Further Demonstrating a Growing Preference for its Innovative GentleWave® Procedure

  2/14/2023

  Sonendo, Inc., a leading dental technology company and developer of the GentleWave® System, announced the results of its latest survey, which revealed high consumer interest levels in its innovative technology.

• BIOLASE REJECTS SONENDO'S PATENTLY ABSURD CLAIMS

  1/25/2023

  BIOLASE, Inc. (NASDAQ: BIOL), the world's leading dental laser company, today released the following statement in response to the attempt by Sonendo, Inc., through its wholly-owned subsidiary PIPStek LLC (Sonendo), to use patent litigation to try to save Sonendo's diminished position and reputation in the marketplace. 

• Sonendo® Announces Health Canada Regulatory Approval for Next Generation GentleWave® G4 System

  11/1/2022

  Sonendo , Inc. (NYSE: SONX), a leading dental technology company and developer of the GentleWave® System, today announced that it has received Health Canada regulatory approval for commercial sales of its recently announced GentleWave G4 System.

• Sonendo, Inc. to Report Third Quarter 2022 Financial Results on November 9, 2022

  10/19/2022

  Sonendo, Inc. today announced that it will report financial results for the third quarter 2022 after the market close on Wednesday, November 9th , 2022.

• Sonendo® Announces Next Generation GentleWave® G4 System

  10/18/2022

  Sonendo, Inc. today announced the release of the GentleWave G4 System, the next generation of its innovative technology platform designed to treat tooth decay.

• Sonendo®, Inc. Announces Second Annual EndoCon®, An Endodontic Conference on Innovation

  10/11/2022

  Sonendo , Inc. today announced its second annual EndoCon , a nationally recognized endodontic conference focused on innovation.

• Sonendo, Inc. Announces $63 Million Private Placement

  9/23/2022

  Sonendo, Inc. (NYSE: SONX), a leading dental technology company and developer of the GentleWave® System, today announced a private placement of common stock and pre-funded warrants, resulting in gross proceeds of $63 million.

• Sonendo® Sponsors Inaugural Women in Endodontics Summit

  9/20/2022

  Sonendo ® Sponsors Inaugural Women in Endodontics Summit.

• Sonendo, Inc. to Present at the Morgan Stanley 20th Annual Global Healthcare Conference

  8/23/2022

  Sonendo, Inc., a leading dental technology company and developer of the GentleWave® System, announced that management will be participating in the upcoming Morgan Stanley 20th Annual Global Healthcare Conference.

• Sonendo, Inc. to Report Second Quarter 2022 Financial Results on August 10, 2022

  7/19/2022

  Sonendo, Inc. (“Sonendo”) (NYSE: SONX), a leading dental technology company and developer of the GentleWave® System, today announced that it will report financial results for the second quarter 2022 after the market close on Wednesday, August 10, 2022.